People using weight loss jabs shed far fewer pounds in the real world than in clinical trials, researchers have found.
Jabs such as Wegovy and Mounjaro, which contain the drugs semaglutide and tirzepatide respectively, have transformed the treatment of obesity, with studies suggesting the former can help people lose up to 20% of their body weight after 72 weeks of treatment.
